Company / Current Liabilities
Dyne Therapeutics, Inc. Current Liabilities History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$42.3M
FY2024
5-year range
$11.0M / $51.1M
FY2020-FY2024
Trend
-17.3%
vs FY2023
Sector context
#158 of 215
Health Care
What the data says
At $42M, Dyne Therapeutics, Inc.'s current liabilities ranks #58 of 215 in the Health Care sector. Current Liabilities has fluctuated over the past 6 years, ranging from $2M in FY2019 to $51M in FY2023.
Based on SEC 10-K filings.
$42M in FY2024 with a 5-year CAGR of +78.1%.
Increased from $28M to $42M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +13.7%
- 5-Year CAGR
- +78.1%
- 10-Year CAGR
- -
Sector benchmark
#58 of 215 in Health CareTop 27% of 215This company $42.3M Sector average $1.6B
▼
-97.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +78.1%, indicating consistent growth.
- In FY2024, current liabilities decreased 17.3% year-over-year.
- Ranks #158 out of 215 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $42.3M | -17.3% |
| FY2023 | $51.1M | +81.9% |
| FY2022 | $28.1M | -2.2% |
| FY2021 | $28.7M | +161.9% |
| FY2020 | $11.0M | +365.1% |
| FY2019 | $2.4M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026